Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Loss-of-function mutations in parkin are the major cause of early-onset familial Parkinson's disease. To investigate the pathogenic mechanism by which loss of parkin function causes Parkinson's disease, we generated a mouse model bearing a germline disruption in parkin. Parkin-/- mice are viable and exhibit grossly normal brain morphology. Quantitative in vivo microdialysis revealed an increase in extracellular dopamine concentration in the striatum of parkin-/- mice. Intracellular recordings of medium-sized striatal spiny neurons showed that greater currents are required to induce synaptic responses, suggesting a reduction in synaptic excitability in the absence of parkin. Furthermore, parkin-/- mice exhibit deficits in behavioral paradigms sensitive to dysfunction of the nigrostriatal pathway. The number of dopaminergic neurons in the substantia nigra of parkin-/- mice, however, is normal up to the age of 24 months, in contrast to the substantial loss of nigral neurons characteristic of Parkinson's disease. Steady-state levels of CDCrel-1, synphilin-1, and alpha-synuclein, which were identified previously as substrates of the E3 ubiquitin ligase activity of parkin, are unaltered in parkin-/- brains. Together these findings provide the first evidence for a novel role of parkin in dopamine regulation and nigrostriatal function, and a non-essential role of parkin in the survival of nigral neurons in mice.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, parkin-deficient mice and mice expressing a dominant negative form of Nrdp1 are not reported to have significant neurodegenerative disease171819.”
From Clec16a is Critical for Autolysosome Function and Purkinje Cell Survival (2016) · cites this paper as [18]
In the citing paper
“The lack of reported neurodegeneration in parkin-deficient and Nrdp1 mutant mice171819 makes it unlikely that this interaction explains our finding of neurodegeneration in Clec16a mutant mice.”
From Clec16a is Critical for Autolysosome Function and Purkinje Cell Survival (2016) · cites this paper as [18]
In the citing paper
“Although PINK1 (McWilliams et al, 2018) and PRKN (Goldberg et al, 2003; Perez & Palmiter, 2005) deficiency do not elicit major defects under baseline conditions, defective striatal neural plasticity is observed in prkn− / − mice (Kitada et al, 2009).”
From Autophagy in major human diseases (2021) · cites this paper as Goldberg et al, 2003
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
The unbiased estimation of number and sizes of arbitrary particles using the disector
Sterio, D. C. (1984) · Journal of Microscopy · doi:10.1111/j.1365-2818.1984.tb02501.x · Cited by 2,519
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
Dunham, N. W., & Miya, T. S. (1957) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030460322 · Cited by 1,716
Association between Early-Onset Parkinson's Disease and Mutations in the Parkin Gene
Lücking, C. B., Dürr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B. S., Meco, G., Denèfle, P., Wood, N. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005253422103 · Cited by 1,433
Schallert, T., Fleming, S. M., Leasure, J. L., Tillerson, J. L., & Bland, S. T. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00005-8 · Cited by 1,354
Self-citationNeuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein
Giasson, B. I., Duda, J. E., Quinn, S. M., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2002) · Neuron · doi:10.1016/s0896-6273(02)00682-7 · Cited by 1,266
Research works printed but not linked: 4
- Tanner, 1990, Neurology, 40, 17
- Parsons, 1994, Crit. Rev. Neurobiol., 8, 189
- Walsh, 1992, J. Pharmacol. Exp. Ther., 263, 617
- Schallert, 1988, Vol. 515, 108
Cited by
Items 801–900 of 913
Current Concepts on the Etiology and Pathogenesis of Parkinson Disease
Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50008-5 · Cited by 2
Hatano, T., & Hattori, N. (2011) · Wiley eBooks · doi:10.1002/9780470015902.a0006026.pub2 · Cited by 1
Bureau, S. C. (2022) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2022-14889 · Cited by 1
Ding, C., Ndiaye, P. S., Campbell, S. R., Fry, M. Y., Gong, J., Wienbar, S. R., Gibbs, W. S., Morquette, P., Chao, L. H., Do, M. T. H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.30.615936 · Cited by 1
Genetics in Parkinson's disease
Kurz, M. W. (2006) · NVA (Nasjonalt vitenarkiv)
Mitochondrial Involvement in Neurodegeneration and Aging
Pickrell, A. M. (2012)
Waldmeier, P. C. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50162-9
Kallman, M. J. (2015) · Springer eBooks · doi:10.1007/978-3-319-05392-9_32 · Cited by 1
Hinkle, K. M., & Melrose, H. L. (2011) · InTech eBooks · doi:10.5772/17701
Parkinson disease: identifying different players sharing a common principle
Farooqi, A. A., Arshad, S., Fayyaz, S., Abbas, S., & Bhatti, S. (2011) · Research in Biotechnology
Chapter 5.1 Microdialysis in genetically altered animals
Sotnikova, T. D., & Gainetdinov, R. R. (2006) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(06)16021-x · Cited by 2
Sriram, S. R., Dawson, V. L., & Dawson, T. M. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch10c
Andersson, D. R. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Effects of Alpha-Synuclein on Cellular Homeostasis
Vekrellis, K., Minakaki, G., & Emmanouilidou, E. (2011) · InTech eBooks · doi:10.5772/17637
“1 The proteasome: Structure, regulation and proteolytic function The ubiquitin-proteasome system (UPS) is a major system for intracellular protein degradation, a complex and tightly regulated process (Goldberg et al., 2003).”
BackgroundEarly Behavioral Phenotypes in Mouse Models of Huntington’s and Parkinson’s Diseases
Chesselet, M., Hickey, M. A., Fleming, S. M., & Fernagut, P. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-387-28066-9_33
Self-citationAnimal Models of Neurodegenerative Diseases
Ghorayeb, I., Page, G., Gaillard, A., & Jaber, M. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_3 · Cited by 3
The Molecular Pathway to Neurodegeneration in Parkin‐Related Parkinsonism
Takahashi, R. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch9c
Chapter 2.5 Microdialysis as a platform for multidisciplinary strategies
Urenjak, J., & Obrenovitch, T. P. (2006) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(06)16011-7
Microdevices for Isolating Single Axons for the Study of Axonal Transport in Dopaminergic Neurons
Lu, X. (2013) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7ft8j1n
PARK2: Parkin Mutations Responsible for Familial Parkinson's Disease
Hattori, N., Hatano, T., Machida, Y., Sato, S., & Kubo, S. (2009) · Blue books of neurology · doi:10.1016/b978-1-4160-6641-5.00004-0
Effects of Alzheimer s and Parkinson s disease gene mutation on cell signaling
Dehvari, N. (2009) · Figshare
The Proteasome, Protein Aggregation, and Neurodegeneration
Wilk, S. (2007) · Springer eBooks · doi:10.1007/978-0-387-30379-6_13
Wnt/beta-catenin signaling in midbrain dopaminergic neurons
Rawal, N. (2006) · Figshare
Bernstein, A. I., & O’Malley, K. L. (2009) · Contemporary clinical neuroscience · doi:10.1007/978-1-60327-342-8_11
“have normal brain morphology, identification of parkin substrates has provided some clues as to how parkin mutations may lead to PD [16].”
BackgroundTucker, T. A., Kundert, J. A., Bondareva, A. A., & Schmidt, E. E. (2005) · Immunogenetics · doi:10.1007/s00251-005-0792-4
“1998); however, simple parkin-null mice exhibit less severe neurological defects and are not deficient in dopaminergic neurons (Goldberg et al. 2003).”
BackgroundDie Parkinson‐Krankheit: Molekulare Mechanismen und Genetik
Büeler, H. (2006) · Pharmazie in unserer Zeit · doi:10.1002/pauz.200600167 · Cited by 4
Iglesias, S. S. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Recessive Parkinsonism, Mitochondria and Translational Regulation
Blackinton, J. G. (2008) · Figshare
An optimized optokinetic behavioral assay to assess central nervous system function in mice
Cahill, H. B. (2009) · ProQuest Demo Repository
Mechanism of action of autosomal recessive juvenile parkinsonism gene mutations
Sandebring, A. (2010) · Figshare
A Get‐Together to Tear It Apart
McLelland, G., & Fon, E. A. (2015) · Wiley eBooks · doi:10.1002/9781119017127.ch12
The role of the ubiquitin-proteasome system in neurodegenerative disorders
Verhoef, L. G. G. C. (2006) · Figshare
Mouse and stem cell models of frontotemporal dementia
Orr, M. E. (2012) · Montana State University ScholarWorks (Montana State University)
Dissertation zur Erlangung des Doktorgrades der Fakultät für Chemie und Pharmazie
Schlehe, J. S. (2008)
Cognition and Hippocampal Plasticity in the Mouse Is Altered by Monosomy of a
Sahún, I., Maréchal, D., Pereira, P. L., Nalesso, V., García, J. M. D., Antonarakis, S. E., & Dierssen, M. (2014)
Ubiquitination by Parkin — Implications in Parkinson’s Disease
Ravichandran, S., Dawson, T. M., & Dawson, V. L. (2006) · Springer eBooks · doi:10.1007/0-387-28500-8_13
Gautam, A. H. (2010) · Rutgers University Community Repository (Rutgers University) · doi:10.7282/t30c4vjx
The Effects of Melatonin with Memantin on MPTP-Induced Parkinson Model in Male Mice
Talebi, R., Alimoradian, A., & Sadegh, M. (2015) · DOAJ (DOAJ: Directory of Open Access Journals)
The Polg Mutator Phenotype Does Not Cause Dopaminergic Neurodegeneration in DJ-1-
Hauser, D. N., Primiani, C. T., Langston, R. G., & Kumaran, R. (2015)
The Neuroprotective Role of Micronutrients in Parkinson’s Disease
Malkus, K. A., Tsika, E., & Ischiropoulos, H. (2009) · doi:10.1201/9781420073522-7
Role of Mitochondria in Parkinson’s Disease and Huntington’s Disease
Schapira, A. H. V. (2012) · Oxidative stress and disease · doi:10.1201/b12308-23
Electrophysiological Analysis of Movement Disorders in Mice
Rao, S. P., André, V. M., Cepeda, C., & Levine, M. S. (2011) · Neuromethods · doi:10.1007/978-1-61779-298-4_11
Self-citationBasal Ganglia Disorders in Genetic Models and Experimentally Induced Lesions
Lalonde, R., & Strazielle, C. (2009) · Neuromethods · doi:10.1007/978-1-60761-474-6_5
Applications of Nanotechnology in Movement Disorders
Pezeshkian, P., Lizárraga, K. J., Gorgulho, A. A., & Salles, A. D. (2013) · CRC Press eBooks · doi:10.1201/b15274-31
Impaired Dopamine–Glutamate Receptor Interactions in Some Neurological Disorders
Hickey, M. A., & Cepeda, C. (2011) · Frontiers in neuroscience · doi:10.1201/b11284-11
Self-citation6.1 Dopamine and Motor Function in Rat and Mouse Models of Parkinson’s Disease
Schallert, T. J., & Fleming, S. M. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195373035.003.0019
Self-citationModel Organisms and Neurogenetics
Krantz, D. E., & Jackson, G. R. (2007) · Medical psychiatry · doi:10.3109/9781420019544.006
Buhlman, L. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-42139-1_10
Basu, S. (2017) · STARS (University of Central Florida) · Cited by 1
Targeting muscarinic receptor subtypes as a therapeutic approach in dystonia and Parkinson's disease
Klisko, D. (2017) · Research Portal (King's College London)
Parkinson's Disease: Is It aT oxicSyndrome?
Aziz, A., Ghanem, A., Abdel-Ghaffar, H., & Salama, M. (2010)
Killinger, B. A. (2017) · Human Biology
Molekulare Mechanismen der Neurodegeneration und Gentherapie für die Parkinson-Krankheit
Büeler, H. (2004) · Forum Médical Suisse ‒ Swiss Medical Forum · doi:10.4414/smf.2004.05087
Cell Therapy for Parkinson’s Disease
Chen, Z. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00049-x · Cited by 3
Dhanushkodi, N. R., & Haque, M. E. (2018) · Springer eBooks · doi:10.1007/978-981-13-0944-1_2
Rat Model of Pre-Motor Parkinson's Disease: Behavioral and MRI Characterization.
Rane, P. (2011) · Digital WPI
Masoud, S. T. (2017) · TSpace (University of Toronto)
de Snoo, M. L. (2018) · TSpace (University of Toronto)
Characterization of PARL-Mediated Intramembrane Proteolysis
Lysyk, L. (2019) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-hht2-ek58
Parkinson hastalığının hayvan modelleri ve kök hücre temelli deneysel çalışmalar
Sezen, G. B., Çivelek, E., Kabataş, S., Diren, F., & Akkoç, T. (2021) · Sinir Sistemi Cerrahisi Dergisi · doi:10.54306/sscd.2021.42204
Role of mitophagy in muscle growth and metabolism
Peker, N. (2017) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/72691
The Ubiquitin–Proteasome System in Parkinson's Disease
McNaught, K. S. P. (2007) · Wiley eBooks · doi:10.1002/9783527619320.ch8c
Sriram, S. R., Dawson, V. L., & Dawson, T. M. (2007) · Wiley eBooks · doi:10.1002/9783527620234.ch10
Autosomal Recessive Parkinson' Disease Related to Parkin ( PARK2 ) Mutations
Hatano, T., Ueno, S., Okuzumi, A., Mori, A., Oji, Y., & Hattori, N. (2022) · Wiley eBooks · doi:10.1002/9780470015902.a0029466
Zhao, X. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737211509.793579398
The Molecular Pathway to Neurodegeneration in Parkin‐Related Parkinsonism
Takahashi, R. (2007) · Wiley eBooks · doi:10.1002/9783527620234.ch9
Mitochondrial dysfunction and its consequences in the context of neurodegeneration
Key, J. (2021) · Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) · doi:10.21248/gups.62414
Animal models of Parkinson’s disease and related disorders
Petzinger, G. M., & Jakowec, M. W. (2013) · Informa Healthcare eBooks · doi:10.3109/9781841849096.014
Faculty Opinions recommendation of Parkin and PINK1 mitigate STING-induced inflammation.
Schumacher, B. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733846349.793551630
The Neuroprotective Role of Micronutrients in Parkinson’s Disease
Tsika, E., Ischiropoulos, H., & Malkus, K. A. (2009) · Oxidative stress and disease · doi:10.1201/9781420073522.ch2
Miller, G. W. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.736495117.793564509
Behavioral and Cytological Differences between Two Parkinson’s Disease Experimental Models
Ávila-Costa, M. R., Ordóñez-Librado, J. L., Gutiérrez-Valdez, A. L., Sánchez-Betancourt, J., Ibarra-Gutiérrez, M. T., Reyna-Velazquez, P. E., Anaya-Martínez, V., Caballero, C. A. G., Montiel-Flores, E., Dorado-Martínez, C., et al. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.108268
Kinsella, R. L., Kimmey, J. M., Smirnov, A., Woodson, R., Gaggioli, M. R., Chavez, S. M., Kreamalmeyer, D., & Stallings, C. L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.04.515221
“where autophagy targets old and damaged mitochondria to the lysosome for degradation (56,57).”
BackgroundParkinson’s Disease - Animal Models, Current Therapies and Clinical Trials
Yenisetti, S. C., Koza, Z., Kumar, D., Singh, S. K., & Ganeshpurkar, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100831
Animal Models and the Pathogenesis of Parkinson's Disease
Castaño, J. G., Iglesias, T., & de Yébenes, J. G. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781849731843-00113
Animal Models of Parkinson's Disease
Rideout, H. J., & Stefanis, L. (2011) · Royal Society of Chemistry eBooks · doi:10.1039/9781849732758-00086 · Cited by 3
Chauhan, H., Carruthers, N., Stemmer, P. M., Schneider, B. P., & Moszczyńska, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.21.604458
Rawi, S. A., Tyers, P., Barker, R. A., & Laman, H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.28.615591
Modeling of Parkinson's Disease in Different Models
Subhan, I., & Siddique, Y. H. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273326866240922193029 · Cited by 1
PINK1-Parkin quality control mitophagy pathway in Parkinson’s disease
Thayer, J. A., & Narendra, D. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15260-3.00013-2
Mitochondrial Autophagy in Brain
Watzlawik, J. O., Hou, X., Fiesel, F. C., & Springer, W. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_9
Metabolic regulatory proteins play an intermediate role in diabetes and Parkinson’s disease
Roy, R., Paul, S., & Chattopadhyay, K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33355-2.00038-4
Mouse Models of Inherited Human Neurodegenerative Disease
Herrup, K. (2007) · Elsevier eBooks · doi:10.1016/b978-012369454-6/50075-3
Yokota, M., Kakuta, S., Shiga, T., Ishikawa, K.-I., Okano, H., Hattori, N., Akamatsu, W., & Koike, M. (2021) · Figshare · doi:10.6084/m9.figshare.14303019
Additional file 1 of Parkin coregulates glutathione metabolism in adult mammalian brain
El Kodsi, D. N., Tokarew, J. M., Sengupta, R., Lengacher, N. A., Chatterji, A., Nguyen, A., Boston, H., Jiang, Q., Palmberg, C., Pileggi, C. A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26563309
Yokota, M., Kakuta, S., Shiga, T., Ishikawa, K.-I., Okano, H., Hattori, N., Akamatsu, W., & Koike, M. (2021) · Figshare · doi:10.6084/m9.figshare.14303022
Kim, E.-Y., Kim, J.-E., Kim, Y.-E., Choi, B., Sohn, D. H., Park, S.-O., Chung, Y.-H., Kim, Y., Robinson, W. H., Kim, Y.-G., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26573491
Yokota, M., Kakuta, S., Shiga, T., Ishikawa, K.-I., Okano, H., Hattori, N., Akamatsu, W., & Koike, M. (2021) · Figshare · doi:10.6084/m9.figshare.14303016
Étude de la fonction transcriptionnelle de la parkine dans les cancers cérébraux
Rouland, L. (2019) · theses.fr (ABES) · doi:10.70675/144669dcz5f62z47dcz9bd6z551bd742d8f9
Neumane, S. (2011) · theses.fr (ABES) · doi:10.70675/4cb9b747z6b13z46eazb3cbzb58a8bffabf2
Metadata
- Authors
- Goldberg, M. S., Fleming, S. M., Palacino, J. J., Cepeda, C., Lam, H. A., Bhatnagar, A., Meloni, E. G., Wu, N., Ackerson, L. C., Klapstein, G. J., Gajendiran, M., Roth, B. L., Chesselet, M.-F., Maidment, N. T., Levine, M. S., & Shen, J.
- Affiliations
- Brigham and Women's Hospital (US)
- University of California, Los Angeles (US)
- Case Western Reserve University (US)
- Corresponding author
- Shen, Jie
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-10
- Volume
- 278
- Issue
- 44
- Pages
- 43628-43635
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2088962120
- Cited by
- 913
- References
- 72
- Citations by year
- 2026: 8 · 2025: 25 · 2024: 35 · 2023: 27 · 2022: 45 · 2021: 39 · 2020: 39 · 2019: 25 · 2018: 39 · 2017: 40 · 2016: 29 · 2015: 34 · 2014: 41 · 2013: 43 · 2012: 36
- FWCI
- 33.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6206 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- Parkin, Parkinson's disease, nigrostriatal pathway, dopaminergic neurons, substantia nigra, striatum, dopaminergic modulation, synaptic excitability, spiny neurons, E3 ubiquitin ligase, alpha-synuclein, synphilin-1, neuronal survival
- MeSH terms
- Alleles, Animals, Behavior, Animal, Brain, Chromatography, High Pressure Liquid, Disease Models, Animal, Dopamine, Electrophysiology, Mice, Transgenic, Models, Genetic, Neurons, Parkinson Disease, Receptors, Dopamine, Substantia Nigra, Time Factors, Blotting, Western, Germ-Line Mutation, Ubiquitin-Protein Ligases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.